NDC 67184-0535

Decitabine

Decitabine

Decitabine is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Qilu Pharmaceutical Co., Ltd.. The primary component is Decitabine.

Product ID67184-0535_0afb3dc7-6072-4a53-acc4-59589fb8491e
NDC67184-0535
Product TypeHuman Prescription Drug
Proprietary NameDecitabine
Generic NameDecitabine
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-04-12
Marketing CategoryANDA /
Application NumberANDA212826
Labeler NameQilu Pharmaceutical Co., Ltd.
Substance NameDECITABINE
Active Ingredient Strength50 mg/20mL
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 67184-0535-1

1 VIAL in 1 CARTON (67184-0535-1) > 20 mL in 1 VIAL
Marketing Start Date2021-04-12
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Decitabine" or generic name "Decitabine"

NDCBrand NameGeneric Name
0143-9385decitabinedecitabine
0781-3139DecitabineDecitabine
0781-3296DecitabineDecitabine
16714-749DecitabineDecitabine
16714-928DecitabineDecitabine
16729-224Decitabinedecitabine
25021-231decitabinedecitabine
42737-110DecitabineDecitabine
43598-348DecitabineDecitabine
43598-427DecitabineDecitabine
47335-361decitabinedecitabine
50742-430DECITABINEdecitabine
55111-556DecitabineDecitabine
55150-376DecitabineDecitabine
68001-347DecitabineDecitabine
69097-285DecitabineDecitabine
67457-316DecitabineDecitabine
64679-067DecitabineDecitabine
68001-422DecitabineDecitabine
69539-115DecitabineDecitabine
63323-825DecitabineDecitabine
68180-738decitabinedecitabine
70121-1644DecitabineDecitabine
72205-031DecitabineDecitabine
72205-036DecitabineDecitabine
75834-190DECITABINEDECITABINE
72603-107DecitabineDecitabine
59148-046Dacogendecitabine
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.